The present invention relates to an organic electronic device comprising a semiconductor layer which comprises a mixture of isomeric compounds.

The present invention relates to a compound of formula (I) for use in organic electronic devices, a composition comprising a compound of formula (IV) and at least one compound of formula (IVa) to (IVd), an organic semiconductor layer comprising the compound or composition, an organic electronic device comprising the organic semiconductor layer, and a display device comprising the organic electronic device.

The present invention relates to a compound of formula (I) and an organic electronic device comprising a semiconductor layer which comprises a compound of formula (I).

The present invention relates to an organic electronic device comprising a compound of formula (I) and a display device comprising the organic electronic device. The invention further relates to novel compounds of formula (I) which can be of use in organic electronic devices.

The present invention relates to an improved process for the preparation of enzalutamide by conventional synthesis, which avoids utilization of microwave irradiation and noxious reagents. The present invention also relates to an improved process for preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which is an intermediate in the synthesis of Enzalutamide.

The present invention relates to an improved process for the preparation of enzalutamide by conventional synthesis, which avoids utilization of microwave irradiation and noxious reagents. The present invention also relates to an improved process for preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which is an intermediate in the synthesis of Enzalutamide.

The present invention relates to a novel phenoxyacetic acid derivative represented by the general formula (I), preparation method thereof and use of a pharmaceutical composition containing the derivative in preparing a medicament for treating diabetes and metabolic syndrome. The phenoxyacetic acid derivatives have excellent in vivo hypoglycemic activity, which can be used for preventing or treating diabetes.

An organic compound represented by formula [1]. ##STR00001## In the formula rings Q represented by formula [1-1] are each independently present at positions *1 and *2 such that positions * of the rings Q correspond to the positions *1 and *2. The rings Q may be the same or different. R.sub.4 and R.sub.5 represent groups each independently selected from the group consisting of a hydrogen atom and a substituted or unsubstituted aryl group. The rings Q are aromatic hydrocarbons. R.sub.1 to R.sub.3 represent groups each independently selected from the group consisting of a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, and a cyano group. At least one of R.sub.1 to R.sub.3 represents a cyano group.

An organic compound represented by formula [1]. ##STR00001## In the formula rings Q represented by formula [1-1] are each independently present at positions *1 and *2 such that positions * of the rings Q correspond to the positions *1 and *2. The rings Q may be the same or different. R.sub.4 and R.sub.5 represent groups each independently selected from the group consisting of a hydrogen atom and a substituted or unsubstituted aryl group. The rings Q are aromatic hydrocarbons. R.sub.1 to R.sub.3 represent groups each independently selected from the group consisting of a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, and a cyano group. At least one of R.sub.1 to R.sub.3 represents a cyano group.

A compound for an organic photoelectric device includes at least one of a compound represented by Chemical Formula 1, a compound represented by Chemical Formula 2 and a combination thereof.